Theradaptive
Theradaptive, Inc.
Theradaptive aims to redefine the regenerative medicine field by delivering therapeutics to any location in the body with precision.
theradaptive.com · Frederick, MD
Funding event
The round itself, as filedInferred stageSeries B
Sold of offered$36.2M of $77.9M
Filed2026-08-04
Days since filing61
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- Yes
- Date of first sale
- 2026-07-21
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Luis AlvarezExecutive Officer · Director
- David StewartExecutive Officer · Director
- Ted A. MeyersDirector
- George ShanineDirector
- Patrick ZhangDirector
- David HarringtonDirector
- Jeffrey DunnDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged46.4% sold2.4 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-231
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
- Material Handler - Biotech ManufacturingSEP 24open 10 days
Also raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-03, against 71 in the 28 days before.